Search results for: 'cmo ad pfa clinical'

12 May 2025  |  Global  |  Market Research

Clinical Decision Support System Market, Global, 2024–2030

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

Infographics

×

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support sy...

Per- and polyfluoroalkyl substances (PFAS) present substantial environmental and health risks. Their complex structure makes them resistant to natural breakdown and allows them to accumulate in living organisms, posing a potential health risk. Growing evidence of PFAS contamination in surface water, groundwater, wastewater, soil, and air is compell...

The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...

Changing regulatory landscapes significantly impact the chemical industry s evolution in technological advancement, product development, vertical integration, and consolidation activities. In a recent Frost & Sullivan report titled The Impact of Regulations on the Chemical Industry (PE52), we found that one of the key areas of regulation is in P...

Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...

30 Oct 2024  |  Global  |  Market Research

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

Infographics

×

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...

Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...

19 Sep 2023  |  North America  |  Market Research

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

Infographics

×

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...